Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs

Koenraad Blot; Martin C. Michel

doi:10.1111/j.1365-2125.2012.04180.x

Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs

Koenraad Blot
, Martin C. Michel

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	209-210
Journal	British journal of clinical pharmacology
Volume	74
Issue number	1
DOIs	https://doi.org/10.1111/j.1365-2125.2012.04180.x
Publication status	Published - 2012

Access to Document

10.1111/j.1365-2125.2012.04180.x

Cite this

@article{b587ec5422a944ca863ea0f77da4dfc9,

title = "Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs",

author = "Koenraad Blot and Michel, \{Martin C.\}",

year = "2012",

doi = "10.1111/j.1365-2125.2012.04180.x",

language = "English",

volume = "74",

pages = "209--210",

journal = "British journal of clinical pharmacology",

issn = "0306-5251",

publisher = "Wiley Blackwell",

number = "1",

}

Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs. / Blot, Koenraad; Michel, Martin C.
In: British journal of clinical pharmacology, Vol. 74, No. 1, 2012, p. 209-210.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs

AU - Blot, Koenraad

AU - Michel, Martin C.

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1365-2125.2012.04180.x

DO - 10.1111/j.1365-2125.2012.04180.x

M3 - Comment/Letter to the editor

C2 - 22242895

SN - 0306-5251

VL - 74

SP - 209

EP - 210

JO - British journal of clinical pharmacology

JF - British journal of clinical pharmacology

IS - 1

ER -